341 related articles for article (PubMed ID: 28575276)
1. Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.
Xiao X; Yang H; Arutiunian V; Fang Y; Besse G; Morimoto C; Zirkle B; Chen XS
Nucleic Acids Res; 2017 Jul; 45(12):7494-7506. PubMed ID: 28575276
[TBL] [Abstract][Full Text] [Related]
2. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
[TBL] [Abstract][Full Text] [Related]
5. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
[TBL] [Abstract][Full Text] [Related]
6. The acidic domain is a unique structural feature of the splicing factor SYNCRIP.
Beuck C; Williamson JR; Wüthrich K; Serrano P
Protein Sci; 2016 Aug; 25(8):1545-50. PubMed ID: 27081926
[TBL] [Abstract][Full Text] [Related]
7. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
Liu M; Mallinger A; Tortorici M; Newbatt Y; Richards M; Mirza A; van Montfort RLM; Burke R; Blagg J; Kaserer T
ACS Chem Biol; 2018 Sep; 13(9):2427-2432. PubMed ID: 30130388
[TBL] [Abstract][Full Text] [Related]
9. Selectively Modulating Conformational States of USP7 Catalytic Domain for Activation.
Özen A; Rougé L; Bashore C; Hearn BR; Skelton NJ; Dueber EC
Structure; 2018 Jan; 26(1):72-84.e7. PubMed ID: 29249604
[TBL] [Abstract][Full Text] [Related]
10. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A
Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187
[TBL] [Abstract][Full Text] [Related]
11. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
[TBL] [Abstract][Full Text] [Related]
12. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Oligonucleotide Selectivity of APOBEC3B.
Wagner JR; Demir Ö; Carpenter MA; Aihara H; Harki DA; Harris RS; Amaro RE
J Chem Inf Model; 2019 May; 59(5):2264-2273. PubMed ID: 30130104
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
[TBL] [Abstract][Full Text] [Related]
15. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
[TBL] [Abstract][Full Text] [Related]
16. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
[TBL] [Abstract][Full Text] [Related]
17. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
[TBL] [Abstract][Full Text] [Related]
18. Catalytically impaired TrpA subunit of tryptophan synthase from Chlamydia trachomatis is an allosteric regulator of TrpB.
Michalska K; Wellington S; Maltseva N; Jedrzejczak R; Selem-Mojica N; Rosas-Becerra LR; Barona-Gómez F; Hung DT; Joachimiak A
Protein Sci; 2021 Sep; 30(9):1904-1918. PubMed ID: 34107106
[TBL] [Abstract][Full Text] [Related]
19. Molecular Interplay between the Dimer Interface and the Substrate-Binding Site of Human Peptidylarginine Deiminase 4.
Lee CY; Lin CC; Liu YL; Liu GY; Liu JH; Hung HC
Sci Rep; 2017 Feb; 7():42662. PubMed ID: 28209966
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
